Pixyl

About:

AI-Powered Brain Image Analysis for Enhanced Patient Care

Website: https://pixyl.ai/

Twitter/X: pixylmedical

Top Investors: Bpifrance, Elaia, Holnest

Description:

Pixyl’s neuroimaging cloud platform facilitates data-driven and value-based patient care by making decision-critical neuroimaging information accessible to clinicians, when it matters. We deliver automatic neuroimaging biomarker extraction for improved insight and decision-making in clinical studies and routine clinical practice. Our cloud-based solutions are designed for seamless integration into the workflows of imaging CROs, neuroradiologists and neurologists. Our platform, Pixyl.Neuro, leverages advanced machine learning methods to deliver quantitative measures of brain atrophy and/or lesion quantification and classification for MS, Stroke, and neurodegenerative diseases.

Total Funding Amount:

2.8M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

La Tronche, Rhone-Alpes, France

Founded Date:

2015-01-01

Contact Email:

contact(AT)pixyl.io

Founders:

Senan Doyle

Number of Employees:

11-50

Last Funding Date:

2021-04-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai